📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

TRACERx Renal: tracking renal cancer evolution through therapy. (2017)

First Author: TRACERx Renal Consortium

Attributed to: Lethal renal cell carcinoma sub-clones: Defining mechanisms of tumour evolution, treatment resistance and immune escape. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/nrurol.2017.112

PubMed Identifier: 28720862

Publication URI: http://europepmc.org/abstract/MED/28720862

Type: Journal Article/Review

Volume: 14

Parent Publication: Nature reviews. Urology

Issue: 10

ISSN: 1759-4812